FIELD: medicine, pharmacy. SUBSTANCE: invention relates to use of pharmaceutical composition consisting of sodium alginate and potassium hydrocarbonate used for treatment of patients with esophageal reflux, gastritis, dyspepsia or ulcer disease. Use of potassium hydrocarbonate provides to increase sodium alginate concentration and to exclude problems associated with preparation thickening. EFFECT: enhanced effectiveness of preparation, improved properties of composition. 6 cl, 24 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED COMPOSITIONS AND IMPROVEMENTS ASSOCIATED THEREWITH | 2003 |
|
RU2317087C2 |
| COMPOSITIONS OF PARTICLES CONTAINING ALGINATE OR ALGINIC ACID | 2006 |
|
RU2441648C2 |
| IMPROVEMENT OF COMPOSITIONS OR WHATEVER IS RELEVANT TO COMPOSITIONS | 2009 |
|
RU2493829C2 |
| METHOD OF PREPARING MORPHINE DERIVATIVES | 0 |
|
SU856381A3 |
| THICKENED COMPOSITIONS | 2004 |
|
RU2324711C2 |
| METHOD OF PRODUCING DERIVATIVES OF IMIDAZOLIN OR THEIR NON-TOXIC SALTS | 0 |
|
SU1217257A3 |
| METHOD OF PRODUCING IMIDAZOLINE DERIVATIVES | 0 |
|
SU1197566A3 |
| METHOD OF OBTAINING 2-/2-(1,4-BENZODIOXANILE)/-2-IMIDAZOLINE HYDROCHLORIDE | 0 |
|
SU1128837A3 |
| METHOD OF PREPARING TETRAPEPTIDES | 0 |
|
SU793386A3 |
| BIOADHESIVE LIQUID COMPOSITION, ESSENTIALLY WATER-FREE | 2004 |
|
RU2336092C2 |
